Wordt geladen...
AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neonate Pompe Mice
Hepatocyte-restricted, AAV-mediated gene transfer is being used to provide sustained, tolerogenic transgene expression in gene therapy. However, given the episomal status of the AAV genome, this approach cannot be applied to pediatric disorders when hepatocyte proliferation may result in significant...
Bewaard in:
| Gepubliceerd in: | Mol Ther Methods Clin Dev |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Gene & Cell Therapy
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6299151/ https://ncbi.nlm.nih.gov/pubmed/30581888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2018.11.002 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|